Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Globus Medical, Inc. stock logo
GMED
Globus Medical
$73.18
+0.9%
$81.78
$49.33
$94.93
$10.07B1.191.02 million shs1.08 million shs
Hologic, Inc. stock logo
HOLX
Hologic
$61.77
+0.7%
$65.08
$60.34
$84.67
$13.86B0.971.80 million shs2.04 million shs
Integer Holdings Co. stock logo
ITGR
Integer
$117.94
+0.8%
$130.01
$107.11
$146.36
$3.96B1.24325,980 shs861,894 shs
Masimo Co. stock logo
MASI
Masimo
$166.60
+1.9%
$174.67
$101.61
$194.88
$8.84B1.04637,153 shs444,658 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Globus Medical, Inc. stock logo
GMED
Globus Medical
+0.96%-3.74%-8.91%-11.52%+36.43%
Hologic, Inc. stock logo
HOLX
Hologic
+0.73%-0.19%-2.55%-14.32%-20.77%
Integer Holdings Co. stock logo
ITGR
Integer
+0.73%+0.69%-4.12%-11.00%+1.08%
Masimo Co. stock logo
MASI
Masimo
+1.86%-0.60%-11.74%+0.79%+13.45%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Globus Medical, Inc. stock logo
GMED
Globus Medical
4.9682 of 5 stars
4.45.00.04.13.63.31.9
Hologic, Inc. stock logo
HOLX
Hologic
4.81 of 5 stars
4.23.00.04.32.81.72.5
Integer Holdings Co. stock logo
ITGR
Integer
2.3001 of 5 stars
3.41.00.00.02.71.71.3
Masimo Co. stock logo
MASI
Masimo
4.025 of 5 stars
2.42.00.04.23.92.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.75
Moderate Buy$97.0932.67% Upside
Hologic, Inc. stock logo
HOLX
Hologic
2.41
Hold$84.6236.98% Upside
Integer Holdings Co. stock logo
ITGR
Integer
2.78
Moderate Buy$148.5625.96% Upside
Masimo Co. stock logo
MASI
Masimo
2.83
Moderate Buy$194.8016.93% Upside

Current Analyst Ratings Breakdown

Latest ITGR, HOLX, GMED, and MASI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/28/2025
Integer Holdings Co. stock logo
ITGR
Integer
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$145.00
3/18/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$90.00 ➝ $82.00
3/18/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
3/4/2025
Hologic, Inc. stock logo
HOLX
Hologic
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$80.00 ➝ $70.00
3/3/2025
Hologic, Inc. stock logo
HOLX
Hologic
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
2/26/2025
Masimo Co. stock logo
MASI
Masimo
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$210.00 ➝ $215.00
2/26/2025
Masimo Co. stock logo
MASI
Masimo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$193.00 ➝ $205.00
2/26/2025
Masimo Co. stock logo
MASI
Masimo
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
2/24/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$100.00 ➝ $103.00
2/21/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$92.00 ➝ $94.00
2/21/2025
Globus Medical, Inc. stock logo
GMED
Globus Medical
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$95.00 ➝ $93.00
(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Globus Medical, Inc. stock logo
GMED
Globus Medical
$2.52B4.00$3.14 per share23.32$29.32 per share2.50
Hologic, Inc. stock logo
HOLX
Hologic
$4.04B3.43$5.28 per share11.69$21.27 per share2.90
Integer Holdings Co. stock logo
ITGR
Integer
$1.72B2.31$7.77 per share15.18$48.27 per share2.44
Masimo Co. stock logo
MASI
Masimo
$2.09B4.30$5.42 per share30.74$25.79 per share6.46
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Globus Medical, Inc. stock logo
GMED
Globus Medical
$122.87M$0.7597.5718.161.614.09%10.83%8.63%5/6/2025 (Estimated)
Hologic, Inc. stock logo
HOLX
Hologic
$789.50M$3.1719.4913.372.1418.42%19.72%10.94%5/1/2025 (Estimated)
Integer Holdings Co. stock logo
ITGR
Integer
$90.65M$3.3635.1017.741.726.92%11.65%5.89%4/24/2025 (Estimated)
Masimo Co. stock logo
MASI
Masimo
$81.50M-$5.70114.9035.98N/A3.85%14.98%6.95%5/6/2025 (Estimated)

Latest ITGR, HOLX, GMED, and MASI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/24/2025N/A
Integer Holdings Co. stock logo
ITGR
Integer
$1.28N/AN/AN/A$428.51 millionN/A
2/25/2025Q4 2024
Masimo Co. stock logo
MASI
Masimo
$1.42$1.80+$0.38-$6.52$593.35 million$600.70 million
2/20/2025Q4 2024
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.74$0.84+$0.10$0.19$646.19 million$657.29 million
2/20/2025Q4 2024
Integer Holdings Co. stock logo
ITGR
Integer
$1.46$1.43-$0.03$0.90$446.28 million$449.50 million
2/5/2025Q1 2025
Hologic, Inc. stock logo
HOLX
Hologic
$1.02$1.03+$0.01$0.87$1.02 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Hologic, Inc. stock logo
HOLX
Hologic
N/AN/AN/AN/AN/A
Integer Holdings Co. stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
2.51
1.64
Hologic, Inc. stock logo
HOLX
Hologic
0.52
3.49
2.78
Integer Holdings Co. stock logo
ITGR
Integer
0.62
2.95
2.09
Masimo Co. stock logo
MASI
Masimo
0.50
2.01
1.11

Institutional Ownership

CompanyInstitutional Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Hologic, Inc. stock logo
HOLX
Hologic
94.73%
Integer Holdings Co. stock logo
ITGR
Integer
99.29%
Masimo Co. stock logo
MASI
Masimo
85.96%

Insider Ownership

CompanyInsider Ownership
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.54%
Hologic, Inc. stock logo
HOLX
Hologic
1.88%
Integer Holdings Co. stock logo
ITGR
Integer
2.00%
Masimo Co. stock logo
MASI
Masimo
9.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
2,600137.54 million110.92 millionOptionable
Hologic, Inc. stock logo
HOLX
Hologic
6,940224.39 million220.17 millionOptionable
Integer Holdings Co. stock logo
ITGR
Integer
10,50033.62 million32.87 millionOptionable
Masimo Co. stock logo
MASI
Masimo
6,20054.04 million48.35 millionOptionable

Recent News About These Companies

How Is The Market Feeling About Masimo?
DexCom names Jon Coleman as chief commercial officer
Dexcom picks longtime Masimo exec as next CCO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Globus Medical stock logo

Globus Medical NYSE:GMED

$73.18 +0.63 (+0.87%)
Closing price 03/31/2025 03:59 PM Eastern
Extended Trading
$73.16 -0.02 (-0.03%)
As of 03/31/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Hologic stock logo

Hologic NASDAQ:HOLX

$61.77 +0.45 (+0.73%)
Closing price 03/31/2025 04:00 PM Eastern
Extended Trading
$61.68 -0.09 (-0.15%)
As of 03/31/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Integer stock logo

Integer NYSE:ITGR

$117.94 +0.99 (+0.85%)
Closing price 03/31/2025 03:59 PM Eastern
Extended Trading
$118.04 +0.10 (+0.08%)
As of 03/31/2025 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Masimo stock logo

Masimo NASDAQ:MASI

$166.60 +3.05 (+1.86%)
Closing price 03/31/2025 04:00 PM Eastern
Extended Trading
$167.22 +0.62 (+0.37%)
As of 03/31/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.